News
BIOYF
10.88
-1.81%
-0.20
FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years
Barchart · 04/01 07:30
BioSyent Announces Grant of Restricted Share Units
Barchart · 03/24 16:30
BioSyent GAAP EPS of C$0.17, revenue of C$9.67M
Seeking Alpha · 03/19 21:32
BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Barchart · 03/12 16:30
BioSyent acquires Oral Science
Seeking Alpha · 02/09 12:57
BioSyent to Acquire Oral Science Inc.
Barchart · 02/09 06:30
BioSyent  raises quarterly dividend by 10% to CAD 0.055/share
Seeking Alpha · 01/29 22:23
BioSyent Declares First Quarter 2026 Dividend
Barchart · 01/29 15:30
These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice
Benzinga · 12/03/2025 20:57
BioSyent declares CAD 0.05 dividend
Seeking Alpha · 11/21/2025 11:16
BioSyent  GAAP EPS of C$0.23, revenue of C$12.22M
Seeking Alpha · 11/20/2025 22:35
BioSyent Declares Fourth Quarter 2025 Dividend
Barchart · 11/20/2025 16:29
Beyond the S&P 500: Finding Overlooked Opportunities in Small Caps
Barchart · 09/30/2025 10:53
Weekly Report: what happened at BIOYF last week (0908-0912)?
Weekly Report · 09/15/2025 10:08
Weekly Report: what happened at BIOYF last week (0901-0905)?
Weekly Report · 09/08/2025 10:09
Weekly Report: what happened at BIOYF last week (0825-0829)?
Weekly Report · 09/01/2025 10:07
Weekly Report: what happened at BIOYF last week (0818-0822)?
Weekly Report · 08/25/2025 10:12
BioSyent declares CAD 0.05 dividend
Seeking Alpha · 08/22/2025 04:49
BioSyent Declares Third Quarter 2025 Dividend
Barchart · 08/21/2025 15:43
Weekly Report: what happened at BIOYF last week (0811-0815)?
Weekly Report · 08/18/2025 10:08
More
Webull provides a variety of real-time BIOYF stock news. You can receive the latest news about Biosyent through multiple platforms. This information may help you make smarter investment decisions.
About BIOYF
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., sources, acquires or in-licenses and further develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., and Hedley Technologies (USA) Inc., a wholly owned subsidiary, operates the Company’s business marketing biologically and health-friendly non-chemical insecticides. The Company’s products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn and Tibella, among others. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. FeraMAX Pd Therapeutic 150 is for the treatment of iron deficiency anemia. The Company also provides specialized healthcare products for dental hygiene and oral health.